Latest Breaking News On - Tissue products - Page 8 : comparemela.com

: Key trends in the market include increasing research and development activities, increasing cases of influenza, ongoing clinical trials on plant-based vaccine, inorganic activities such as collaborations by the market players, and others. Increasing number of research and development activities for improving the effectiveness of plant-based vaccines is expected to bolster growth of the plant-based vaccines market. For instance, on November 10, 2020, Medicago Inc. started conducting clinical trials for the production of plant-based COVID-19 vaccine. The company is planning to initiate Phase II/ III clinical trial after receiving positive results from the Phase I trial. Moreover, Medicago Inc. is also developing VLP Quadrivalent plant-based vaccine for Seasonal Influenza. Currently, the influenza vaccine is in Phase II of the clinical trial. In both the cases, Nicotiana Benthamiana, an Australian tobacco plant, is used for the production of COVID-19 and Influenza vaccine.

United statesUnited kingdomAsia pacificLeaf expression systems ltdLumen bioscience incPlantform corporationIbio incBio incInfectious disease research instituteCreative biolabs incMedicago incBritish american tobacco plcLife sciences incCoherent market insightsGlobal plant based vaccines marketNicotiana benthamiana